CDKN1A and hepatocellular carcinoma: Though only NRAS and YWHAZ were inversely correlated with miR-22 expression in HCC patients, these results confirm that miR-22 has the potential to inhibit AKT3, CDKN1A, DDIT4, GNB4, NRAS and YWHAZ expression in HCC cells.